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Transbronchial lung cryobiopsy guided by radial mini-probe 
endobronchial ultrasound in interstitial lung diseases — 
a multicenter prospective study
Abstract
Introduction: Transbronchial lung cryobiopsy (TBLC) is commonly used in diagnosing interstitial lung diseases (ILDs). A general 
anesthesia with endotracheal intubation, balloon blockers and fluoroscopy control is the most common modality. Simplifying the 
procedure without decreasing it’s safety could result in wider use.
Prospective, observational study was conducted in three Polish pulmonology centers to evaluate safety and diagnostic yield of 
TBLC under conscious sedation, without intubation and bronchial blockers and with radial-EBUS guidance instead of fluoroscopy.
Material and methods: In patients suspected of ILD, in accordance with high resolution computer tomography (HRCT) 
selected lung segments were examined with radial-EBUS mini probe without a guide sheath. If the lung infiltrations were 
visible this locations were preferred. If not, specimens were taken from two different segments of the same lobe. Two to 
five biopsies with freezing time 5–8 seconds were performed. Moreover ultrasound examination was used to avoid injury 
of lung vessels.
Results: From March 2017 to September 2019 — 114 patients (M: 59, F: 55) of mean (SD) age 54 (14) years were included to 
the study on the basis of medical history and HRCT. Histopathology was conclusive in 90 (79%) patients and included 16 different 
diagnoses (sarcoidosis, EAA, COP predominantly). 24 inconclusive biopsies of unclassifiable pulmonary fibrosis were followed 
up. Complications included five cases (4.4%) of pneumothorax requiring a chest tube drainage and a minor and moderate bleeding 
in few cases. There was no need for use of balloon bronchial blockers.
Conclusions: TBLC under conscious sedation guided by radial EBUS mini-probe is novel, reasonable and safe technique for 
histological diagnosis of ILDs.
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Introduction
Interstitial lung disease (ILD), also known as 
diffuse parenchymal lung disease is a heteroge-
neous group of conditions. The common patholog-
ical mechanism of these illnesses is the presence 
of inflammation and/or fibrosis in the lung pa-
renchyma. When clinical outcome and radiology 
findings (especially in high resolution computed 
tomography, HRCT) are not sufficient to establish 
proper diagnosis, a pathological assessment of the 
involved lung tissue may be necessary in selected 
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patients. A  transbronchial lung biopsy (TBLB) 
with endoscopic forceps is the most common 
and the least invasive approach. Whereas its high 
value in diagnosing only few ILDs (as sarcoidosis) 
is well established, TBLB is not recommended 
for identifying pulmonary fibrosis. Regarding 
idiopathic pulmonary fibrosis (IPF), either ATS/ 
/ERS/JRS/ALAT (American Thoracic Society/Eu-
ropean Respiratory Society/Japanese Respiratory 
Society/Latin American Thoracic Association) or 
Fleischner Society guidelines recognize a surgical 
lung biopsy (SLB, usually video-assisted thoracic 
surgery lung biopsy — VATS-LB) as a gold stan-
dard and recommend it if HRCT is not conclusive 
[1, 2]. The other important indication for lung bi-
opsy (LB) in patients with diffuse lung infiltrations 
is an exclusion of malignancy. Considering that 
the most common primary lung cancer — adeno-
carcinoma is quite often diagnosed among patients 
with no smoking history and with radiological 
appearance of diffuse lung infiltrates imitating 
ILD, histological assessment is crucial in many 
cases [3, 4]. Patients after VATS-LB often require 
a  few days of hospitalization and face a risk of 
some possible complications, as prolonged air 
leak and bronchopleural fistula, involving in some 
cases reoperation and low but significant mortality 
risk [5, 6]. Considering all these complications, 
the development and widespread introduction of 
minimally invasive methods of LB into the prac-
tice in ILD with pulmonary fibrosis is necessary.
A biopsy with the use of a flexible cryoprobe 
was introduced in clinical practice a  few years 
ago, and initially proved its diagnostic value 
both in endobronchial and transbronchial tissue 
sampling [7, 8]. Studies published to date have 
suggested that diagnostic yield of transbronchial 
lung cryobiopsy (TBLC) in establishing proper 
diagnosis of ILD reaches 70–80% [9–12].
The review of cryobiopsy literature has re-
vealed a lack of TBLC procedure standardization 
[1, 10, 11]. While the basic technique of TBLC 
is nearly the same, the approach how to avoid 
and manage the most common complications: 
pneumothorax and severe bleeding differs. The 
risk of pneumothorax increases when a cryoprobe 
is inserted too far into the bronchi and freezing 
hurts the visceral pleura. On the other hand, 
when a cryoprobe is too close to the pulmonary 
vessels, the risk of severe bleeding is higher.
There is no doubt that choosing a correct site for 
LB and controlling the cryoprobe position during the 
procedure is crucial both for its efficacy and safety. 
The most common method of supervising a position 
of a cryoprobe’s tip is fluoroscopy [10–12].
In our center, a radial endobronchial ultra-
sound miniature probe (r-EBUS) is routinely used 
for diagnosing peripheral solid and semisolid lung 
lesions. A few years ago we introduced r-EBUS 
before performing conventional forceps TBLB 
in diagnosing patients suspected of ILD. In our 
experience in some cases, if lung opacities are 
visible in ultrasound imaging, r-EBUS allows the 
bronchoscopist to choose the best biopsy site. It 
is very useful in localizing vessels of the hilum 
and sometimes even shows the visceral pleura. 
Based on these observations, we designed a study 
for the diagnosis of ILDs with the use of TBLC 
without fluoroscopy but controlled with r-EBUS.
Material and methods
This study was designed as an open-label 
observational prospective trial. It was a multi-
center study conducted in Pulmonary Hospital, 
Zakopane, in John Paul II Hospital, Cracow, and 
in Clinical Hospital of the Silesian Medical Uni-
versity, Katowice, Poland. A study protocol was 
approved by Bioethical Committee of District 
Medical Association, Cracow, Poland (129/KBL/ 
/OIL/2017).
Consecutive patients in whom the decision 
of lung biopsy was made, in the process of ILD 
diagnosing were included in the study. Qualifi-
cation for LB was made on the basis of clinical 
outcome and radiology assessed by experts in 
pulmonology and radiology according to the 
British Thoracic Society and previous edition 
of ATS/ERS/JRS/ALAT guidelines [13, 14]. The 
main exclusion criteria were as follows: lack of 
patient’s agreement, age below 18 years and stan-
dard contraindications for invasive endoscopy 
such as inappropriate hemostasis parameters, 
instable cardiovascular disease and/or heart fail-
ure and pulmonary hypertension. After receiving 
the informed consent, the TBLC procedure was 
performed. During the endoscopy, the patient 
was in the supine position under conscious se-
dation: fentanyl (0.05–0.1 mg) and midazolam 
(2.5–7.5 mg) were administered intravenously. 
A pulse oximetry monitoring was mandatory 
and oxygen supply was provided when it was 
necessary. A whole procedure was performed by 
a trained endoscopist with the assistance of two 
endoscopy nurses. A flexible videobronchoscope 
(BFT180 or BFT190 Olympus, Tokyo, Japan) with 
a 2.8–3.0 mm working channel was introduced 
orally, without endotracheal intubation with 
a tube or rigid bronchoscope. After topical ad-
ministration of a 2% lignocaine and bronchial 
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Figure 1. Ultrasound imaging of the visceral pleura (white arrow) 
obtained with radial endobronchial ultrasound mini-probe — rEBUS. 
With the consent of the Archives of Endoscopy Unit of Pulmonary 
Hospital, Zakopane
Figure 2. Ultrasound imaging of the subsegmental pulmonary artery (white 
arrow) obtained with radial endobronchial ultrasound mini-probe (rEBUS). 
Biopsy in this site would cause significant bleeding. With the consent of the 
Archives of Endoscopy Unit of Pulmonary Hospital, Zakopane
tree inspection, the ultrasound radial miniature 
probe UM-S20-20R (Olympus, Tokyo, Japan) was 
used. Selected, according to HRCT, lung regions 
were examined with r-EBUS in order to choose 
the optimal site for TBLC. The ultrasound probe 
without a guide sheath was inserted as far as 
possible (sometimes a specific ultrasound sign 
of the visceral pleura was visible — Figure 1). 
A slow withdrawing of the ultrasound probe 
with controlling the distance between the pleura 
(if visible) and hilar vessels (Figure 2) allowed 
to identify the safest area for the biopsy. The 
additional advantage of this method was that in 
some cases the lung infiltrates were visible in the 
ultrasound image (Figure 3), and if there were 
no vessels close to the lesions, the exact location 
of the biopsy could be established. Following 
an ultrasonographic examination, the flexible 
Figure 3. Ultrasound imaging of interstitial lung infiltration obtained with radial endobronchial ultrasound mini-probe (rEBUS). A. Cryptogenic organizing 
pneumonia; B. Usual interstitial pneumonia. With the consent of the Archives of Endoscopy Unit of Pulmonary Hospital, Zakopane
cryoprobe (diameter 1.9 mm, length 900 mm; 
ERBE, Tubingen, Germany) was introduced 
to the working channel of the bronchoscope. 
After placing its tip in previously selected site 
(according to r-EBUS examination), TBLC was 
performed with freezing time of 5–8 sec (mean 
7 sec). Two to five biopsies were taken from two 
different segments of the same lobe, whereas 
in diffused lung infiltrates, lower lobes were 
chosen. If ultrasound examination was negative 
for the presence of lung infiltrations, distance 
from the visceral pleura was approximately 
1–2 cm. The bronchoscope with the inserted 
cryoprobe and lung tissue adhered to the tip of 
the probe was taken out of the airways en bloc. 
As the specimen was placed in the saline (Fig-
ure 4), the cryoprobe was pulled out, and the 
same scope was inserted into the bronchial tree 
A B
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Figure 5. A microscopic imaging of cryobiopsy (hematoxilin and eosin 
staining). Usual interstitial pneumonia (UIP) associated with histologic 
pattern (patchy fibrosis and honeycomb). With the consent of the 
Archives of Pathology Department of Pulmonary Hospital, Zakopane
again to assess and, if necessary, to manage the 
bleeding. The time without eye control of the 
bronchial tree was about 15–30 seconds. The 
balloon catheter for lobar occlusion after TBLC 
was not used. For safety reasons, the double- 
-lumen endotracheal tube was prepared in case 
of major bleeding requiring patient’s intubation 
and separated lung ventilation. The bleeding 
after biopsy was qualified as minor, moderate 
and major according to its management: minor 
— no action needed, self-limiting bleeding; mod-
erate — bleeding managed endoscopically (cold 
saline, adrenaline solution, segmental bronchi 
blockage with the scope); major when additional 
actions were needed (intubation, admission to 
the intensive care, surgery). The chest X-ray due 
to the pneumothorax control was done within 
2–4 hours after TBLC or immediately according 
to the physician decision. After the procedure, 
the specimens were transferred from saline to 
a 10% formaldehyde solution and then sent to 
the Pathology Department, where were assessed 
by two independent pathologists after standard 
Hematoxylin & Eosin (HE) staining (Figure 5). 
The final diagnosis was established in the dis-
cussion by the multidisciplinary team compris-
ing experts in pulmonology, radiology and lung 
pathology.
Statistical analysis
A statistical analysis was conducted on the 
basis of descriptive statistic as the arithmetic 
mean with standard deviation. The results were 
used to calculate the diagnostic yield.
Sarcoidosis; 
32; 28% 
 
 
 
 
 
 
 
NSIP; 2; 1%
RA-ILD; 2; 2% 
TB; 2; 2%
Other ILD (see text); 
8; 7%
UIP; 8; 7%
Silicosis; 
9; 8%
COP; 9; 8%
EAA; 18; 16%
 
Non-diagnostic; 
24; 21%
Figure 6. Histological diagnoses in a group of 114 patients with ILD 
(n; %). EAA — extrinsic allergic alveolitis; COP — cryptogenic organi-
zing pneumonia; ILD — interstitial lung disease; NSIP — nonspecific 
interstitial pneumonia; RA-ILD — rheumatoid arthritis-related ILD; TB 
— tuberculosis; UIP — usual interstitial pneumonia.
Figure 4. Two lung tissue specimens obtained with flexible cry-
oprobe and the third one attached to the cryoprobe’s tip. With the 
consent of the Archives of Endoscopy Unit of Pulmonary Hospital, 
Zakopane
Results
From March 2017 to September 2019 one 
hundred and fourteen patients, 59 (52%) males 
and 55 (48%) females of mean (SD) age 54 (14) 
years were enrolled in the study. The time of the 
whole procedure was 10–20 min (mean 15 min). 
The lung tissue obtained by r-EBUS-TBLC was 
found sufficient for pathological evaluation in 
all cases. A diameter of specimen was 5–10 mm 
(mean 7 mm). Histopathology was conclusive for 
final diagnosis in 90 (79%) cases. The most com-
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mon histological diagnosis was sarcoidosis — 32 
(28.1%) patients, then extrinsic allergic alveolitis 
(EAA) — 18 (15.8%) cases, silicosis and crypto-
genic organizing pneumonia (COP) — 9 (7.9%) 
individuals each. Usual interstitial pneumonia 
(UIP) was diagnosed in 8 (7%) cases. Tuberculosis, 
rheumatoid arthritis-related ILD (RA-ILD) and 
non-specific interstitial pneumonia (NSIP) were 
diagnosed in two cases each, and hemosiderosis, 
Langerhans cell histiocytosis (LCH), lymphocytic 
interstitial pneumonia (LIP), exogenous lipoid 
pneumonia (ELP), smoking-related interstitial 
fibrosis (SRIF), vasculitis, scleroderma and mixed 
connective tissue disease-related ILD (SCL-ILD 
and MCTD-ILD) in one case each (Figure 6). 
Among twenty four non-diagnostic biopsies, 
unclassifiable lung fibrosis and normal lung (in 
few cases with the presence of macrophages with 
brown deposits characteristic for smokers) were 
the most common pathological findings. Patients 
with non-conclusive TBLC are followed up and 
further subgroup analyses are planned after es-
tablishing final diagnoses for the whole group.
Complications included only five cases 
(4.4%) of pneumothorax requiring a chest tube 
drainage and minor and moderate bleeding in 
few cases.
Discussion
Whereas specimens obtained by conven-
tional TBLB are often found by pathologists not 
adequate for histological evaluation because 
they are too small and damaged by forceps, those 
obtained by TBLC are bigger and free of crushing 
artifacts. In some studies, the results of TBLC in 
ILD were even comparable to VATS-LB, and the 
procedure was safer [9]. A diagnostic yield of 
TBLC in different reports varies from 51% to 98%. 
Among the procedure-related complications, the 
most common is pneumothorax (0–33%). Other 
reported complications include serious bleeding 
up to 20%, acute exacerbation (AE) of ILD up to 4% 
and death in most cases due to AE-IPF (up to 4%) 
[10–12]. The results of our study have shown the 
diagnostic yield on the level of 79% and the com-
plication rate of 4.4% (exclusively pneumothorax). 
No serious bleeding was noted in our study. It can 
be connected with guidance method we used to 
visualize the pulmonary vessels. Almost all data 
about the safety of TBLC come from studies with 
fluoroscopic guidance. In two studies, in which 
authors didn’t use any guidance for TBLC, compli-
cation ratio was 0% and 12% for serious bleeding 
and 4.7% and 8% for pneumothorax [15, 16]. 
Taking into consideration the mentioned data and 
our results in safety area, it is disputable whether 
the use of fluoroscopy has significant impact on 
the procedure safety. More data, especially from 
comparative randomized trials is needed.
The high percentage of sarcoidosis diagnosed 
in our study (28.1%) must be noted and commen-
ted due to its possible influence on the diagnostic 
yield. It must be underlined that only patients 
without lymphadenopathy (stage III and IV) and 
with negative conventional bronchoscopy (endo-
bronchial mucous biopsy, TBLB) were included 
in the study.
Although the usefulness of TBLC for col-
lecting adequate samples seems to be out of the 
question, there are no standards when it comes to 
the exact procedure technique. The fluoroscopic 
guidance, endotracheal tube or rigid bronchosco-
pe intubation with deep sedation or general 
anesthesia is the most common way of perfor-
ming TBLC. For safety reasons, it is important to 
know if a  freezing tip of the flexible cryoprobe 
is distant enough both from the chest wall and 
hilar vessels. In twenty six of TBLC reports from 
2009 to 2017 analyzed by Lentz RJ et al., only in 
2 studies fluoroscopic guidance was not used (in 
one only in 40% cases) [10].
Experts preparing recommendations for 
IPF management very carefully analyzed data 
regarding safety and efficacy of the TBLC, and 
they found it promising but not standardized 
enough to be widely recommended. They have 
pointed out that “a standardized procedure for 
lung cryobiopsy that optimizes the balance be-
tween diagnostic yield and complications needs 
to be developed among experts currently engaged 
with the procedure” [1]. They have suggested the 
experts already performing this procedure should 
work on its standardization and do not recom-
mend introducing this procedure by new centers 
before its value and safety will be determined. 
However it seems to be a very cautious statement, 
but it might be justified in the light of recently 
published data showing very poor concordance 
between TBLC and surgical lung biopsy (SLB). 
Romagnoli et al. showed that TBLC would have 
led to a different treatment if SLB was not perfor-
med in 11 of 21 (52%) cases [17]. This small but 
well-designed study cooled down the enthusiasm 
about TBLC in ILDs and showed a lack of strong 
data comparing SLB with TBLC.
Our idea of using r-EBUS control simplifies 
the whole procedure and avoids X-ray exposure 
without decreasing diagnostic yield, and the 
safety of the procedure is high. Whereas the 
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fluoroscopy provides guidance mainly for safety 
reasons, the r-EBUS assessment of the lung before 
TBLC may also sometimes help to choose the most 
proper biopsy site (because some types of infiltra-
tions are visible in ultrasound image). Although 
cost/effectiveness analysis was not the purpose 
of the study, in our opinion, it is worth noticing 
that simplifying the method (no use of endotra-
cheal intubation, balloon blockers or fluoroscopic 
control) should lead to the cost reduction. 
At the time of preparing our study protocol, 
there were no data regarding its efficacy and 
safety profile. During last years a few papers were 
published and summarized by Gupta et al. [18]. 
Most of the analyzed studies presented the role 
of r-EBUS in peripheral nodule cryobiopsy. The 
authors found and examined only three studies 
(including our preliminary report in 20 patients) 
describing the role of r-EBUS cryobiopsies in 
diffuse parenchymal lung disease. In their conc-
lusions they have found it to be a  feasible and 
safe procedure with high diagnostic yield. The 
studies on the role of r-EBUS-guided TBLC are 
currently under way (i.e. in Vanderbilt University 
Medical Center). In our opinion, this technique 
should be further investigated and compared in 
randomized trials, both with TBLC under fluoro-
scopic control and balloon bronchial blockers in 
intubated patients (how most centers perform 
it) and with SLB. Without comparative studies, 
strong recommendation on the use and method 
of performing TBLC in ILDs will be impossible. 
Conclusions
The results of our study have shown that com-
bination of r-EBUS and TBLC is a novel, reasonable 
and safe technique to diagnose ILDs. It could be an 
alternative way of performing TBLC in ILD patients 
but further comparative trials are required. 
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